Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing attention to peptide-based drugs such as Wegovy, demand for effective peptide therapeutics derived from natural substances is rapidly rising. In particular, peptide metabolites—which are generated when natural proteins break down in the body—are emerging as promising candidates for multifunctional drug development.
Dual-action peptide can target viruses while promoting tissue repair
